Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data [0.03%]
基于CheckMate 227五年数据的混合愈后生存分析评估纳武利尤单抗联合伊匹木单抗对比化疗治疗初治转移性非小细胞肺癌的成本效益分析
Alison D Griffiths,Robert O Young,Yong Yuan et al.
Alison D Griffiths et al.
Objectives: This study assessed the cost-effectiveness of nivolumab plus ipilimumab (NIVO+IPI) versus platinum-doublet chemotherapy (chemo) in untreated metastatic non-small cell lung cancer (NSCLC) using mixture-cure mod...
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India [0.03%]
印度膝关节骨关节炎患者行全膝置换术与非手术治疗的经济学评价研究
Amatullah Sana Qadeer,Ananda Meher,Jennifer Rachel et al.
Amatullah Sana Qadeer et al.
Objective: This study is an economic evaluation of total knee replacement (TKR) in comparison with non-surgical management in India. Methods: ...
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey [0.03%]
新冠肺炎疫情期间COVID-19感染状态与经济成本之间的关联性——来自英国症状监测数字问卷调查的证据
Sung Wook Kim,Caterina Alacevich,Catia Nicodemo et al.
Sung Wook Kim et al.
Introduction: In the absence of a vaccination programme, the coronavirus disease 2019 (COVID-19) pandemic had substantial impacts on population health and wellbeing and health care services. We explored the association be...
F S Mennini,A Marcellusi,P Sciattella et al.
F S Mennini et al.
Background: Breast cancer (BC) constitutes a significant public health challenge in Italy, with a considerable impact on healthcare resources and societal costs. Despite advancements in diagnostics and therapies, the econ...
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis [0.03%]
基于模型的cost-utility分析评价了抗菌药物管理、降钙素原检测和快速血培养鉴定在 sepsis 照护中的卫生经济学价值：一种90天模型-Based成本效用分析
Wendy I Sligl,Charles Yan,Jeff Round et al.
Wendy I Sligl et al.
Objective: We evaluated the cost-effectiveness of a bundled intervention including an antimicrobial stewardship program (ASP), procalcitonin (PCT) testing, and rapid blood culture identification (BCID), compared with pre-...
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review [0.03%]
从社会角度审视血友病的经济负担：系统评价
Amr A El-Sayed,Nancy S Bolous
Amr A El-Sayed
Introduction: Haemophilia is a rare genetic bleeding disorder that leads to musculoskeletal complications. The high cost of haemophilia treatment necessitates a thorough evaluation of its economic burden. However, due to ...
From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment [0.03%]
从临床到非临床结果的HIV治疗：经济和组织影响评估
Ferrario Lucrezia,Menzaghi Barbara,Rizzardini Giuliano et al.
Ferrario Lucrezia et al.
Objective: The aim of this study was to define the economic and organizational impacts related to a broader utilization of bictegravir/emtricitabine/alafenamide (BIC/FTC/TAF) in Italian clinical practice. ...
CMS's Drug Price Negotiation Program 2023 Patient-Focused Listening Sessions: A Descriptive Analysis of Speaker Remarks [0.03%]
2023年CMS药物价格谈判计划患者聚焦听证会发言内容描述性分析报告
Julie A Patterson,Tyler D Wagner,Rayan K Salih et al.
Julie A Patterson et al.
Background: The US Centers for Medicare and Medicaid Services (CMS) held patient-focused listening sessions in Fall 2023 for each of the first ten drugs selected for the Inflation Reduction Act's (IRA) Drug Price Negotiat...
Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line Treatment [0.03%]
一线治疗晚期或转移性肾细胞癌患者的不良事件成本分析
Yan Chen,Ella X Du,Manasvi Sundar et al.
Yan Chen et al.
Aim: This study evaluated costs associated with adverse events (AEs) in previously untreated real-world patients with advanced renal cell carcinoma (aRCC) in the USA. ...
Digital Versus Paper-Based Consent from the UK NHS Perspective: A Micro-costing Analysis [0.03%]
英国NHS视角下的数字同意与纸质同意的微成本分析
Rachel Houten,Mohammad Iqbal Hussain,Antony P Martin et al.
Rachel Houten et al.
Background: The paper-based consent pathway can be associated with missing information, error, and inadequate patient comprehension. Digital consent addresses some of these limitations. However, limited research has been ...